levobunolol hydrochloride solution/ drops
bausch & lomb incorporated - levobunolol hydrochloride (unii: o90s49ldhh) (levobunolol - unii:g6317aoi7k) - levobunolol hydrochloride 5 mg in 1 ml - levobunolol hydrochloride ophthalmic solution has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertension. levobunolol hydrochloride ophthalmic solution is contraindicated in those individuals with bronchial asthma, or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second and third degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; or hypersensitivity to any component of these products.
levobunolol hydrochloride solution/ drops
physicians total care, inc. - levobunolol hydrochloride (unii: o90s49ldhh) (levobunolol - unii:g6317aoi7k) - levobunolol hydrochloride 5 mg in 1 ml - levobunolol hydrochloride ophthalmic solution has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertension. levobunolol hydrochloride ophthalmic solution is contraindicated in those individuals with bronchial asthma or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second and third degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; or hypersensitivity to any component of these products.
levobunolol hydrochloride solution/ drops
pacific pharma, inc. - levobunolol hydrochloride (unii: o90s49ldhh) (levobunolol - unii:g6317aoi7k) - levobunolol hydrochloride 2.5 mg in 1 ml - levobunolol hcl ophthalmic solution has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertension. levobunolol hcl ophthalmic solution is contraindicated in those individuals with bronchial asthma or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second and third degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; or hypersensitivity to any component of these products.
levobunolol hydrochloride ophthalmic solution liquid
bausch & lomb pharmaceuticals inc. - levobunolol hydrochloride - liquid - 0.50% - levobunolol hydrochloride 0.50% - beta-adrenergic agents
levobunolol hydrochloride ophthalmic solution liquid
alcon canada inc - levobunolol hydrochloride - liquid - 0.50% - levobunolol hydrochloride 0.50% - beta-adrenergic agents
levobunolol hydrochloride solution
sandoz inc - levobunolol hydrochloride (unii: o90s49ldhh) (levobunolol - unii:g6317aoi7k) - levobunolol hydrochloride 5 mg in 1 ml
betagan- levobunolol hydrochloride solution/ drops
allergan, inc. - levobunolol hydrochloride (unii: o90s49ldhh) (levobunolol - unii:g6317aoi7k) - levobunolol hydrochloride 5 mg in 1 ml - betagan ® ophthalmic solution has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma or ocular hypertension. betagan ® ophthalmic solution is contraindicated in those individuals with bronchial asthma, or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second and third degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; or hypersensitivity to any component of these products.
ratio-levobunolol solution
teva canada limited - levobunolol hydrochloride - solution - 0.25% - levobunolol hydrochloride 0.25% - beta-adrenergic agents
ratio-levobunolol solution
teva canada limited - levobunolol hydrochloride - solution - 0.5% - levobunolol hydrochloride 0.5% - beta-adrenergic agents
betagan 0,50 % eye drops sol. dropper cont.
allergan pharmaceuticals ireland ltd. - levobunolol hydrochloride 5 mg/ml - eye drops, solution - 0,50 % - levobunolol hydrochloride 5 mg/ml - betaxolol